Investing in Aehr Test Systems (AEHR) is a safe bet with a significant edge

As of close of business last night, Aehr Test Systems’s stock clocked out at 15.36, up 0.46% from its previous closing price of $15.29. In other words, the price has increased by $+0.07 from its previous closing price. On the day, 1217727 shares were traded. AEHR reached its highest trading level at $16.57 during the session, while it also had its lowest trading level at $14.84.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .



To gain a deeper understanding of AEHR’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.50 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 415.28. For the most recent quarter (mrq), Quick Ratio is recorded 4.10 and its Current Ratio is at 5.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 when SLAYEN HOWARD T sold 10,000 shares for $18.26 per share. The transaction valued at 182,557 led to the insider holds 180,762 shares of the business.

SLAYEN HOWARD T sold 10,000 shares of AEHR for $175,002 on Aug 10. The Director now owns 190,762 shares after completing the transaction at $17.50 per share. On Aug 09, another insider, SPINK KENNETH B., who serves as the VP of Finance and CFO of the company, sold 17,707 shares for $16.23 each. As a result, the insider received 287,385 and left with 154,673 shares of the company.

Valuation Measures:

As of this moment, Aehr’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.13, and their Forward P/E ratio for the next fiscal year is 14.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.31. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.99 while its Price-to-Book (P/B) ratio in mrq is 8.13.

Stock Price History:

Over the past 52 weeks, AEHR has reached a high of $27.09, while it has fallen to a 52-week low of $6.71. The 50-Day Moving Average of the stock is 14.08, while the 200-Day Moving Average is calculated to be 12.08.

Shares Statistics:

It appears that AEHR traded 1.12M shares on average per day over the past three months and 1.32M shares per day over the past ten days. A total of 27.00M shares are outstanding, with a floating share count of 24.76M. Insiders hold about 5.10% of the company’s shares, while institutions hold 32.20% stake in the company. Shares short for AEHR as of Jul 14, 2022 were 1.01M with a Short Ratio of 1.69, compared to 1.2M on Jun 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 3.76% and a Short% of Float of 4.23%.

Earnings Estimates

As of right now, 1 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.01 for the current quarter, with a high estimate of $0.01 and a low estimate of $0.01, while EPS last year was $-0.02. The consensus estimate for the next quarter is $0.1, with high estimates of $0.1 and low estimates of $0.1.

Analysts are recommending an EPS of between $0.52 and $0.52 for the fiscal current year, implying an average EPS of $0.52. EPS for the following year is $1.04, with 1 analysts recommending between $1.04 and $1.04.

Revenue Estimates

A total of 1 analysts have provided revenue estimates for AEHR’s current fiscal year. The highest revenue estimate was $62.05M, while the lowest revenue estimate was $62.05M, resulting in an average revenue estimate of $62.05M. In the same quarter a year ago, actual revenue was $50.83M, up 22.10% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $99.09M in the next fiscal year. The high estimate is $99.09M and the low estimate is $99.09M. The average revenue growth estimate for next year is up 59.70% from the average revenue estimate for this year.